The current market environment offers unique opportunities for an accredited investor in the medical marijuana / cannabis sector. Potential investors should take the opportunity to evaluate these private placements while they are available during the early stages of financing required by these companies.The big fund managers have yet to enter the U.S. marijuana industry and many, at the moment, are reluctant to invest in the U.S. market due to the uncertainty around the rules and regulations by the U.S. Federal Government.After the big fund managers are given the green light to start investing in this sector, these early investors will benefit from the sectors growth and the share prices will rise with additional buying pressure coming from funds.